Navigation Links
FUJIFILM Enters Advanced Visualization Market

CHICAGO, Nov. 29 /PRNewswire/ -- This year at the Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting, FUJIFILM Medical Systems USA is announcing its entrance into the advanced visualization space with the introduction of Synapse(TM) 3D*. Fujifilm is building on its core strength in image processing by now offering its own advanced imaging capabilities for both general radiographic and cardiovascular applications. The company has also made other significant enhancements to its Synapse(TM) PACS including the introduction of Synapse communications and new features to further aid the interpretation of breast imaging studies.

Synapse 3D

Fujifilm is one of the first major PACS vendors to introduce its own 3D product which offers more than a dozen clinical applications delivering both radiology- and cardiovascular-specific applications such as 2D, 3D, 4D, virtual ultrasound, liver analysis, lung analysis, coronary CT/MR analysis and cardiac fusion. Developed in conjunction with radiologists, cardiologists and surgeons who performed joint research with engineers, Synapse 3D is integrated right into Fujifilm's Synapse PACS application - eliminating the need for a 3rd party software. The application is enterprise capable, and is available at any workstation where Synapse PACS is available. Powered by server-based rendering technology, Synapse 3D enables the radiologist or the technologist to perform the renderings.

"With Fujifilm's history of innovative image processing and analysis, it's a natural extension for us to draw on our strength and provide our own advanced visualization technology," explained Jim Morgan, Fujifilm's Executive Director of Marketing, Medical Informatics. "While we have been providing MIP/MPR functionality as well as integrations to third party 3D applications, customers will have the option to select Synapse 3D which will be integrated directly into their Synapse PACS and Synapse Cardiovascular applications, providing the most efficient workflow for all clinicians," continued Morgan.

Already available in other parts of the world including Japan, Synapse 3D is currently installed in four evaluation sites in the U.S. Physicians at Albert Einstein Medical Center, Philadelphia, Penn., Yale University Medical Center, New Haven, Conn., Margaret Pardee Memorial Hospital, Hendersonville, N.C., and USC Medical Center, Los Angeles, Calif., have been using the product and providing feedback prior to its commercial release which is expected in the first quarter of 2010. One of the evaluators is Meng Law, MD, Director of Neuroradiology, Los Angeles County Hospital and USC Medical Center, who presented findings on his use and review of the product at the International Cancer Imaging Society conference held in early October in Salzburg, Austria.

"In my evaluation, Synapse 3D has proven to be critical in terms of the diagnostic and outcomes value it provides," said Dr. Law. "The PET CT Fusion capabilities, in particular, have performed exceptionally well, and we look forward to using the systems in the future. We have also utilized the advanced MR capabilities for processing diffusion and perfusion data of the brain as well as using the calcium scoring tool for a research project investigating the utility of neurovascular calcium scoring for predicting stroke, "continued Law.

Enterprise Imaging

Synapse has undergone significant refinements to support not only the image and information managements needs of radiology and cardiology departments, as well as other critical care departments including oncology, pathology and ophthalmology. The ability to provide both storage and distribution of images throughout the enterprise in both DICOM and web formats is critical to the integrated healthcare network. Additional features including smart forwarding and smart prefetching functionally have been added to allow images to flow seamless from and to Synapse PACS from third-party systems.

Synapse Communications

A comprehensive toolset enabling compliance with American College of Radiology (ACR) and Joint Commission on Accreditation of Healthcare Organizations (JCAHO) industry guidelines, Synapse communications is available as an option to Synapse PACS. It includes a variety of features to enhance communication and help radiology departments and reading groups meet the ever changing business and regulatory requirements of radiology information management. Specific features include critical results reporting, peer review, instant messaging, QA discrepancy tracking and embedded task list management. Synapse Communications is embedded into the Synapse PACS user interface to maximize performance and minimize user clicks.

Full Field Digital Mammography Enhancements

Fujifilm is demonstrating a new works in progress FFDM feature of Synapse PACS designed to work with any vendor to further aid the interpretation of breast imaging exams. These specialized advanced visualization tools are tailored to meet the specific demands of breast imaging and reaffirm Fujifilm's ongoing commitment to assist in efficient and accurate detection of breast disease.

Breast bound detection and alignment Automatically left-right aligns images with optimum "zoom to breast borders", as is required for appropriate interpretation. This feature increases workflow efficiency by enabling the radiologist to immediately begin reading the images without having to manually prepare them.

About FUJIFILM Medical Systems USA, Inc.

FUJIFILM Medical Systems USA, Inc. is one of the FUJIFILM Corporation family of companies with 70 years of imaging experience and more than $28 billion in sales. Its extensive portfolio includes diagnostic imaging products and informatics solutions to meet the needs of healthcare facilities in both outpatient and hospital settings. The Synapse brand of integrated products includes Synapse(TM) PACS, Synapse(TM) RIS, Synapse(TM) cardiovascular and Synapse(TM) women's imaging; it provides a complete Web-based solution for managing, storing and distributing images and information throughout all healthcare facilities. Additionally, Synapse(TM) managed services offers fault-tolerant solutions including PACS and RIS hosting, and disaster recovery. FUJIFILM Medical Systems USA is headquartered in Stamford, CT. For more information visit

© 2009 FUJIFILM Medical Systems USA, Inc.

Synapse 3D requires FDA 510(k) clearance and is not yet available for sale in the U.S.

SOURCE FUJIFILM Medical Systems USA, Inc.

SOURCE FUJIFILM Medical Systems USA, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
5. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
6. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
9. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
10. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
11. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
Post Your Comments:
(Date:12/1/2015)... and PITTSBURGH , Dec. ... announced that it expects to be the first to ... funded by international donors, TLE400 (Tenofovir Disoproxyl Fumarate 300 ... for $99 per patient, per year. Mylan partnered with ... The significantly reduced price could generate savings of tens ...
(Date:12/1/2015)...  Six months of adjunctive metformin therapy does not improve ... to new research from T1D Exchange and funded ... beneficial effect on measures of obesity, including weight and BMI. ... Journal of the American Medical Association , are from the ... on overweight and obese adolescents with type 1 diabetes. ...
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... On Tuesday 27 Oct 2015, ... educate the personnel on spinal decompression therapy and offer his professional help. , ... The benefits come from creating negative intradiscal pressure which is conducive to retraction ...
(Date:12/1/2015)... ... 01, 2015 , ... World Patent Marketing , a vertically integrated ... allows for easier packing and organizing of items into one big, portable jar. , ... Cooper, CEO and Creative Director of World Patent Marketing and Desa Industries Inc ...
(Date:12/1/2015)... ME (PRWEB) , ... December 01, 2015 , ... Royal ... reports a new study that found post-menopausal women who took the nutritional supplement creatine, ... than women who trained but did not take creatine. , The report is part ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an article ... a discrimination claim against the U.S. Department of Health and Human Services, claiming that ... (ACA) plans are breaking the clause in the law prohibiting the denial of coverage ...
(Date:12/1/2015)... Los Angeles, CA (PRWEB) , ... December 01, 2015 , ... ... the United States, today announced that its iconic bottle has won top honors in ... drinks category. The Company also announced that it has been selected as a ...
Breaking Medicine News(10 mins):